Conjugate vaccine for group B streptococcus

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

42419711, 4242441, 530403, A61K 3940, A61K 39385, A61K 3909, C07K 104

Patent

active

058434445

ABSTRACT:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.

REFERENCES:
patent: 4207414 (1980-06-01), Kasper
patent: 4284537 (1981-08-01), Beachey
patent: 4324887 (1982-04-01), Kasper
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4356263 (1982-10-01), Kasper
patent: 4367221 (1983-01-01), Kasper
patent: 4367222 (1983-01-01), Kasper
patent: 4367223 (1983-01-01), Kasper
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4619828 (1986-10-01), Gordon
patent: 4673574 (1987-06-01), Anderson
patent: 4757134 (1988-07-01), Blake et al.
patent: 4761283 (1988-08-01), Anderson
patent: 4789735 (1988-12-01), Frank et al.
patent: 4830852 (1989-05-01), Marburg et al.
patent: 4902506 (1990-02-01), Anderson et al.
patent: 5302386 (1994-04-01), Kasper et al.
patent: 5648241 (1997-07-01), Michel et al.
Paoletti et al. Immunogenicity of Group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infection and Immunity vol. 64 677-679, 1996.
Madoff et al. Maternal immunization of mice with Group B Streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J. Clin. Invest. vol. 94 286-292, 1994.
Givner et al. Pooled human IgG hyperimmune for type III Group B Streptococci: Evaluation against multiple strains in vitro and in experimental disease. J. Infectious Diseases vol. 163 1141-1145, 1991.
Anderson, B. E. et al., "A Protective Protein Antigen of Rickettsia rickettsii Has Tandemly Repeated, Near-Identical Sequences", Infect. Immun. 58(9):2760-2769 (Sep. 1990).
Avery, O. T. et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins", J. Exp. Med. 54:437-447 (1931).
Baker, C.J. and Kasper, D.L., "Group B Streptococcal Vaccines," Rev. Infect. Dis. 7(4):458-467 (1985).
Baker, C. J. et al., "Immunization of Pregnant Women With A Polysaccharide Vaccine of Group B Streptococcus", New Eng. J. Med. 319(18):1180-1185 (Nov. 1988).
Baker, C.J. et al., "Immunization to Prevent Group B Streptococcal Disease: Victories and Vexations," J. Inf. Dis. 161(5):917-921 (May 1990).
Bevanger, L. et al., "Complete and Incomplete Ibc Protein Fraction in Group B Streptococci", Acta path. microbiol. scand. Sect. B 87:51-54 (1979).
Bevanger, L. et al., "The Ibc Protein Fraction of Group B Streptococci Characterization of Protein Antigens Extracted by HCL", Acta path. microbiol. scand. Sect. B. 89:205-209 (1981).
Bevanger, L., "Ibc Proteins as Serotype Markers of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect. B 91:231-234 (1983).
Bevanger, L., "The Ibc Proteins of Group B Streptococci: Isolation of the .alpha. and .beta. Antigens by Immunosorbent Chromatography and Test for Human Serum Antibodies Against the Two Antigens", Acta path. microbiol. immunol. scand. Sect. B 93:113-119 (1985).
Bevanger, L. et al., "Mouse-Protective Antibodies Against the Ibc Proteins of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect. B 93:121-124 (1985).
Bevanger, L. et al., "Characterization of the .alpha. antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody", Acta Pathol. Microbiol. Immunol. Scand. 100(1):57-62 (Jan. 1992).
Bittle, J. L. et al., "Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals", Adv. Vet. Sci. Comp. Med. 33:1-63 (Feb. 1989).
Boyer, K.M. et al., "Human IgG Antibody to Group B Streptococcus Type II: Protection in a Mouse Model," Clin. Res. 34(4):962A (1986).
Brady, L. J. et al., "Identification of Non-Immunoglobulin A-Fc-Binding Forms and Low-Molecular-Weight Secreted Forms of the Group B Streptococcal .beta. Antigen", Infect. Immun. 57(5):1573-1581 (May 1989).
Cleat, P. H. et al., "Cloning and Expression in Escherichia coli of the Ibc Protein Genes of Group B Streptococci: Binding of Human Immunoglobulin A to the Beta Antigen", Infect. Immun. 55(5):1151-1155 (1987).
Coleman, R. T. et al., "Prevention of Neonatal Group B Streptococcal Infections: Advances in Maternal Vaccine Development", Obst. Gynec. 80(2):301-309 (Aug. 1992).
Dailey, D. C. et al., "The Phenotypically Variable Surface Protein of Trichomonas vaginalis Has a Single, Tandemly Repeated Immunodominant Epitope", Infect. Immun. 59(6):2083-2088 (Jun. 1991).
Devi, S.J.N. et al., "Antibodies to immunization of mice with Escherichia coli K92 conjugates: Potential vaccines for groups B and C meningococci and E. coli K1," Proc. Natl. Acad. Sci. USA 88:7175-7179 (Aug. 1991).
Dick, W.E. Jr. and Beurret, M., "Glycoconjugates of Bacterial Carbohydrate Antigens: A Survey and Consideration of Design and Preparation Factors," in Contributions to Microbiology and Immunology, vol. 10, Cruse, J.M. and Lewis R.E. Jr., eds., Karger, Basel, Switzerland (Jul. 1989), pp. 48-114.
Dintzis, R.Z., "Rational Design of Conjugate Vaccines," Pediatr. Res. 32(4):376-385 (Oct. 1992).
Enea, V. et al., "DNA Cloning of Plasmodium falciparum Circumsporozoite Gene: Amino Acid Sequence of Repetitive Epitope", Science 225:628-630 (1984).
Feldman, R. G. et al., "The immune response to the group B streptococcus", Rev. Med. Microbiol. 3(1):52-58 (Jan. 1992).
Ferrieri, P., "Surface-Localized Protein Antigens of Group B Streptococci", Rev. Infect. Dis. 10(Suppl. 2):S363-S366 (Jul.-Aug. 1988).
Fischetti, V. A. et al., "Structure, Function, and Genetics of Streptococcal M Protein", Rev. Infect. Dis. 10(Suppl. 2):S356-S359 (Jul.-Aug. 1988).
Fischetti, V. A. et al., "Common Characteristics of the Surface Proteins from Gram-Positive Cocci", in: Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci, Dunny, G. M. et al., eds., American Society for Microbiology: Washington, D.C., pp. 290-294 (Jul. 1991).
Heden, L.-O. et al., "Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity", Eur. J. Immunol. 21:1481-1490 (Jun. 1991).
Heiman, H.S. and Weisman, L.E., "The Opsonic Antibody Response of Female Rats to Type III Group B Streptococcal Immunization: a Model for Maternal Immunity," Veterin. Immunol. Immunopath. 24:79-89 (Jan. 1990).
Horensky, D. S. et al., "Generation and Analysis of Group B Streptococcal Alpha C Protein Gene Constructs Containing Variable Numbers of Tandem Repeats", Abstracts of the 93rd General Meeting of the American Society for Microbiology, Session 107, p. 107, Abstract D-68 (May 1993).
Insel, R. A., "Maternal Immunization to Prevent Neonatal Infections", New Eng. J. Med. 319(18):1219-1220 (Nov. 1988).
Jennings, H.J. et al., "Conformational Aspects Critical to the Immunospecificity of the Type III Group B Streptococcal Polysaccharide," Biochemistry 20(16):4511-4518 (1981).
Jennings, H.J. and Lugowski, C., "Immunochemistry of Groups A, B, and C Meningococcal Polysaccharide-Tetanus Toxoid Conjugates," J. Immunol. 127(3):1011-1018 (1981).
Jennings, H.J. et al., "Structural Determination of the Capsular Polysaccharide Antigen of Type II Group B Streptococcus," J. Biol. Chem. 258(3):1793-1798 (1983).
Jennings, H.J., "Capsular Polysaccharides as Human Vaccines," in Advances in Carbohydrate Chemistry and Biochemistry, vol. 41, Tipson, R.S. and Horton, D., eds., Academic Press, NY (1983), pp. 155-208.
Jennings, H.J. and Roy, R., "Enhancement of the Immune Response to the Group B Polysaccharide of Neisseria meningitidis by Means of Its Chemical Modification," in The Pathogenic Neisseriae: Proc. 4th Intl. Symp., Schoolnik, G.K. et al., eds., Am. Soc. Microbiol., Washington, D.C. (1985), pp. 628-632.
Jerlstrom, P. G. et al., "The IgA-binding .beta. antigen of the c p

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Conjugate vaccine for group B streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Conjugate vaccine for group B streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate vaccine for group B streptococcus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2393445

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.